Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • Research to Prevent Blindness

This publication has 18 references indexed in Scilit: